These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 16710643

  • 1. Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study.
    Marshall V, Wilton L, Shakir S.
    Acta Diabetol; 2006 May; 43(1):6-13. PubMed ID: 16710643
    [Abstract] [Full Text] [Related]

  • 2. Safety of nateglinide as used in general practice in England: results of a prescription-event monitoring study.
    Twaites B, Wilton LV, Layton D, Shakir SA.
    Acta Diabetol; 2007 Dec; 44(4):233-9. PubMed ID: 17874223
    [Abstract] [Full Text] [Related]

  • 3. Safety profile of orlistat: results of a prescription-event monitoring study.
    Acharya NV, Wilton LV, Shakir SA.
    Int J Obes (Lond); 2006 Nov; 30(11):1645-52. PubMed ID: 16552401
    [Abstract] [Full Text] [Related]

  • 4. The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
    Perrio MJ, Wilton LV, Shakir SA.
    Obesity (Silver Spring); 2007 Nov; 15(11):2712-22. PubMed ID: 18070762
    [Abstract] [Full Text] [Related]

  • 5. The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England.
    Biswas PN, Wilton LV, Shakir SW.
    J Hum Hypertens; 2002 Nov; 16(11):795-803. PubMed ID: 12444541
    [Abstract] [Full Text] [Related]

  • 6. The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England.
    Twaites BR, Wilton LV, Shakir SA.
    J Psychopharmacol; 2007 Jun; 21(4):392-9. PubMed ID: 17656426
    [Abstract] [Full Text] [Related]

  • 7. Safety profile of oxcarbazepine: results from a prescription-event monitoring study.
    Buggy Y, Layton D, Fogg C, Shakir SA.
    Epilepsia; 2010 May; 51(5):818-29. PubMed ID: 20132298
    [Abstract] [Full Text] [Related]

  • 8. The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients.
    Hazell L, Cornelius V, Wilton LV, Shakir SA.
    BJU Int; 2009 Feb; 103(4):506-14. PubMed ID: 18990133
    [Abstract] [Full Text] [Related]

  • 9. Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction.
    Maclennan KM, Boshier A, Wilton LV, Shakir SA.
    BJU Int; 2006 Jul; 98(1):125-31. PubMed ID: 16831156
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999.
    Boshier A, Wilton LV, Shakir SA.
    BJU Int; 2004 Apr; 93(6):796-801. PubMed ID: 15049992
    [Abstract] [Full Text] [Related]

  • 11. A modified prescription-event monitoring study to assess the introduction of Flixotide Evohaler into general practice in England: an example of pharmacovigilance planning and risk monitoring.
    Perrio MJ, Wilton LV, Shakir SA.
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):969-78. PubMed ID: 17476703
    [Abstract] [Full Text] [Related]

  • 12. Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England.
    Kasliwal R, Wilton LV, Shakir SA.
    Drug Saf; 2008 Sep; 31(10):839-50. PubMed ID: 18759508
    [Abstract] [Full Text] [Related]

  • 13. Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study.
    Layton D, Clarke A, Wilton LV, Shakir SA.
    Osteoporos Int; 2005 May; 16(5):490-500. PubMed ID: 15309382
    [Abstract] [Full Text] [Related]

  • 14. Preclinical and clinical studies on safety and tolerability of repaglinide.
    Schatz H.
    Exp Clin Endocrinol Diabetes; 1999 May; 107 Suppl 4():S144-8. PubMed ID: 10522841
    [Abstract] [Full Text] [Related]

  • 15. Safety profile of nicorandil--prescription-event monitoring (PEM) study.
    Dunn N, Freemantle S, Pearce G, Wilton LV, Mann RD.
    Pharmacoepidemiol Drug Saf; 1999 May; 8(3):197-205. PubMed ID: 15073929
    [Abstract] [Full Text] [Related]

  • 16. Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
    Vlckova V, Cornelius V, Kasliwal R, Wilton L, Shakir SA.
    Drug Saf; 2009 May; 32(5):409-18. PubMed ID: 19419235
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000.
    Boshier A, Wilton LV, Shakir SA.
    Eur J Clin Pharmacol; 2003 Dec; 59(10):767-73. PubMed ID: 14615857
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study.
    Kasliwal R, Wilton LV, Shakir SA.
    Drug Saf; 2009 Dec; 32(6):499-507. PubMed ID: 19459717
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.